Search Results - "Andrade Villanueva, J"

Butyrate administration strengthens the intestinal epithelium and improves intestinal dysbiosis in a cholestasis fibrosis model by Peña‐Rodríguez, M., Vega‐Magaña, N., García‐Benavides, Leonel, Zepeda‐Nuño, J.S., Gutierrez‐Silerio, G.Y., González‐Hernández, L.A., Andrade‐Villanueva, J.F., Del Toro‐Arreola, S., Pereira‐Suárez, A.L., Bueno‐Topete, M.R.

“…Aim Intestinal dysfunction in cirrhosis patients is linked to death by bacterial infections. Currently, there is no effective therapy for this complication…”
Get full text

The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection by Figueroa, MI, Camiro‐Zuñiga, A, Belaunzaran‐Zamudio, PF, Sierra Madero, J, Andrade Villanueva, J, Arribas, JR, Lama, JR, Cecchini, DM, Lopardo, G, Crabtree‐Ramírez, B, Gun, A, Patterson, P, Fink, VI, Sued, OG, Cahn, P

“…Objectives To assess the effect of protease inhibitor (PI)‐based dual therapy on CD4/CD8 ratio during the first year of therapy in antiretroviral therapy…”
Get full text

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment‐naïve HIV‐1‐infected patients (the ARTEN study) by Podzamczer, D, Andrade‐Villanueva, J, Clotet, B, Taylor, S, Rockstroh, JK, Reiss, P, Domingo, P, Gellermann, HJ, de Rossi, L, Cairns, V, Soriano, V

“…Objectives Dyslipidaemic effects of antiretrovirals (ARVs) may contribute to increased cardiovascular risk (CR) in HIV‐1‐infected patients. The ARTEN…”
Get full text

Fecal microbiota transplantation for severe complicated C. difficile colitis in a patient with acquired immunodeficiency syndrome by Martínez-Ayala, P, González-Hernández, L A, Amador-Lara, F, Andrade-Villanueva, J, Ramos-Solano, M

Get full text

Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study by Horban, A, Losso, M, Belloso, W, Silk, D, Wolff, M, Alberto Arnaiz, J, Mallon, P, Clark, Andrew, Cooper, David, Fisher, Martin, Gatell, Jose, Kaiser, Rolf, Kelleher, Anthony, Losso, Marcelo, Rockstroh, Juergen, Ruxrungtham, Kiat, Stellbrink, Jurgen, Yeung, Julie, Fsadni, Bertha, Marks, Kat, Suzuki, Kazuo, Rismanto, Nick, Birch, Chris, Schuelter, Eugen, Coughlan, Suzie, Avila, Santiago, Naphassanant, May, Ubolyam, Sasiwimol, Walker, Sarah, DeJesus, Edwin, Berthon‐Jones, Nisha, Espinosa, Natalie, Absar, Noorul, Donaldson, Anna, Guelman, Daniel, Gambardella, Luciana, Valdovinos, Mariana, Arnaiz, Juan, Ramos, Nuria, Boesecke, Christoph, Engelhardt, Angelika, Perry, Nicky, Beckthold, Brenda, Drummond, Fraser, Grant, Carol, Sanchez, Marisa, Viloria, Guillermo, Parlante, Angel, Luchetti, Pablo, Confalonieri, Valeria, Vieni, Ines, Zarate, Abel, Elliot, Julian, Hagenauer, Michelle, Gibson, Abby, Latch, Ngaire, Bloch, Mark, Vincent, Trina, Dwyer, Dominic, Orth, David, Sowden, David, Wadham, Samantha, Donohue, William, Thompson, Jill, Madden, Tracey, Nvene, June, Bryant, Mellissa, Chan, Warmond, Lanteigne, Francois, Mouawad, Rima, Rahal, Ines, Guber, Sergio, Smith, Graham, Allendes, Gladys, Ebeling, Franziska, Hoeper, Kirsten, Faetkenheur, Gerd, Thomas, Ellen, Ingiliz, Patrick, Wienbreyer, Andreas, Jessen, Heiko, Simelane, Sibongile, Oca, Melva Montes, Hernandez, Jesus Eduardo Sanchez, Pulik, Piotr, Sanz‐Moreno, Jose, Puig, Jordi, Domingo, Pere, Callau, Pili, Tovar, Sandra Cuellar, Noval, Manuel Leal, Rivas, Inmaculada, Delgado‐Fernandez, Marcial, Charoenporn, Walairat, Jaisomkom, Pachuen, Richardson, Celia, Fox, Julie, Morris, Shelia, Satyajit, Das, Tucker, James

“…Objectives The Maraviroc Switch (MARCH) study week 48 data demonstrated that maraviroc, a chemokine receptor‐5 (CCR5) inhibitor, was a safe and effective…”
Get full text

Trasplante de microbiota fecal en el tratamiento de colitis grave complicada por C. difficile en un paciente con síndrome de inmunodeficiencia adquirida by Martínez-Ayala, P., González-Hernández, L.A., Amador-Lara, F., Andrade-Villanueva, J., Ramos-Solano, M.

Get full text

Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study by Molina, Jean-Michel, Andrade-Villanueva, Jaime, Echevarria, Juan, Chetchotisakd, Ploenchan, Corral, Jorge, David, Neal, Moyle, Graeme, Mancini, Marco, Percival, Lisa, Yang, Rong, Wirtz, Victoria, Lataillade, Max, Absalon, Judith, McGrath, Donnie

“…BACKGROUND:Once-daily atazanavir/ritonavir demonstrated similar antiviral efficacy to twice-daily lopinavir/ritonavir over 48 weeks, with less gastrointestinal…”
Get full text

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study by Molina, Jean-Michel, Prof, Andrade-Villanueva, Jaime, MD, Echevarria, Juan, MD, Chetchotisakd, Ploenchan, Prof, Corral, Jorge, MD, David, Neal, FCFP [SA], Moyle, Graeme, MD, Mancini, Marco, BS, Percival, Lisa, MS, Yang, Rong, PhD, Thiry, Alexandra, PhD, McGrath, Donnie, MD

“…Summary Background Atazanavir/ritonavir is as effective as lopinavir/ritonavir, with a more favourable lipid profile and less gastrointestinal toxicity, in…”
Get full text

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48 by ORTIZ, Roberto, DEJESUS, Edwin, VANGENEUGDEN, Tony, SPINOSA-GUZMAN, Sabrina, KHANLOU, Homayoon, VORONIN, Evgeniy, VAN LUNZEN, Jan, ANDRADE-VILLANUEVA, Jaime, FOURIE, Jan, DE MEYER, Sandra, DE PAUW, Martine, LEFEBVRE, Eric

“…The present primary analysis of AntiRetroviral Therapy with TMC114 ExaMined In naive Subjects (ARTEMIS) compares the efficacy and safety of once-daily…”
Get full text

Establishment of a prospective cohort of adult HIV positive patients in Latin America (LATINA Prospective Cohort): Baseline data analysis by Loria, G. Rodriguez, Mosqueda, L., Villanueva, J. Andrade, Losso, M., Hercilla, L., Mantilla, M., Lopardo, G.D., Michaan, M.G., Belloso, W.

Get full text

Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol by Cohen, Jordana B., Hanff, Thomas C., Corrales‐Medina, Vicente, William, Preethi, Renna, Nicolas, Rosado‐Santander, Nelson R., Rodriguez‐Mori, Juan E., Spaak, Jonas, Andrade‐Villanueva, Jaime, Chang, Tara I., Barbagelata, Alejandro, Alfonso, Carlos E., Bernales‐Salas, Eduardo, Coacalla, Johanna, Castro‐Callirgos, Carlos Augusto, Tupayachi‐Venero, Karen E., Medina, Carola, Valdivia, Renzo, Villavicencio, Mirko, Vasquez, Charles R., Harhay, Michael O., Chittams, Jesse, Sharkoski, Tiffany, Byrd, James Brian, Edmonston, Daniel L., Sweitzer, Nancy, Chirinos, Julio A.

“…Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus responsible for coronavirus disease 2019 (COVID‐19), is associated with high incidence…”
Get full text

Fecal microbiota transplantation for severe complicated C. difficile colitis in a patient with acquired immunodeficiency syndrome by Martínez-Ayala, P., González-Hernández, L.A., Amador-Lara, F., Andrade-Villanueva, J., Ramos-Solano, M.

Get full text

Once-daily azithromycin in the treatment of adult skin and skin-structure infections by Amaya-Tapia, G, Aguirre-Avalos, G, Andrade-Villanueva, J, Peredo-González, G, Morfín-Otero, R, Esparza-Ahumada, S, Rodríguez-Noriega, E

“…The aim of this prospective, blinded, randomized study was to demonstrate the efficacy and safety of oral azithromycin and dicloxacillin in the treatment of…”
Get more information

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial by Cohen, Jordana B, Hanff, Thomas C, William, Preethi, Sweitzer, Nancy, Rosado-Santander, Nelson R, Medina, Carola, Rodriguez-Mori, Juan E, Renna, Nicolás, Chang, Tara I, Corrales-Medina, Vicente, Andrade-Villanueva, Jaime F, Barbagelata, Alejandro, Cristodulo-Cortez, Roberto, Díaz-Cucho, Omar A, Spaak, Jonas, Alfonso, Carlos E, Valdivia-Vega, Renzo, Villavicencio-Carranza, Mirko, Ayala-García, Ricardo J, Castro-Callirgos, Carlos A, González-Hernández, Luz A, Bernales-Salas, Eduardo F, Coacalla-Guerra, Johanna C, Salinas-Herrera, Cynthia D, Nicolosi, Liliana, Basconcel, Mauro, Byrd, James B, Sharkoski, Tiffany, Bendezú-Huasasquiche, Luis E, Chittams, Jesse, Edmonston, Daniel L, Vasquez, Charles R, Chirinos, Julio A

“…Biological considerations suggest that renin–angiotensin system inhibitors might influence the severity of COVID-19. We aimed to evaluate whether continuing…”
Get full text

Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1-Infected Subjects at 48 Weeks by ZAJDENVERG, Roberto, PODSADECKI, Thomas J, BADAL-FAESEN, Sharlaa, ANDRADE-VILLANUEVA, Jaime, GATHE, Joseph, MINGRONE, Horacio, FREDRICK, Linda M, GAULTIER, Isabelle A, WOODWARD, W. Chris, BERNSTEIN, Barry M

“…To compare the safety and antiviral activity of once (QD) or twice (BID) daily lopinavir/ritonavir (LPV/r) in combination with investigator-selected…”
Get full text

Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study by Andrade-Villanueva, J, Flores-Gaxiola, A, Lopez-Guillen, P, Aguirre-Avalos, G, Morfin-Otero, R, Rodriguez-Noriega, E

“…Lomefloxacin, a new difluorinated quinolone, and trimethoprim/sulfamethoxazole (TMP/SMX) were compared in the treatment of adults with uncomplicated urinary…”
Get more information

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity by Moyle, Graeme J, Andrade-Villanueva, Jaime, Girard, Pierre-Marie, Antinori, Andrea, Salvato, Patricia, Bogner, Johannes R, Hay, Phillip, Santos, Jesús, Astier, Ludovic, Pans, Miranda, Balogh, Agnes, Biguenet, Sophie

“…Abdominal adiposity in HIV-1 patients initiating antiretroviral therapy may be part of a restoration-to-health phenomenon. Lipoatrophy is associated with…”
Get more information

Conflicto de intereses by Martínez-Ayala, P, González-Hernández, L.A, Amador-Lara, F, Andrade-Villanueva, J, Ramos-Solano, M

Get full text

ARV treatment with four nucleosides in HIV–tuberculosis co-infected subjects when efavirenz (EFV) is not an option by Piñeirua-Menendez, A, Meraz-Muñoz, A, Campos-Loza, A, Badial-Hernández, F, Crabtree-Ramirez, B, Andrade-Villanueva, J, Sierra-Madero, J

Get full text

Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study): NVP vs. ATZ/r in naïve HIV-infected patients: ARTEN lipid profiles by Podzamczer, D, Andrade-Villanueva, J, Clotet, B, Taylor, S, Rockstroh, JK, Reiss, P, Domingo, P, Gellermann, HJ, de Rossi, L, Cairns, V, Soriano, V

Get full text